Healthcare & Life Sciences
Global Blood Therapeutics
United Stateswww.gbt.com
Global Blood Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 2 tracked investors.
series-b
series-b
Stage
2
Investors
About Global Blood Therapeutics
Based in the United States, Global Blood Therapeutics is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Global Blood Therapeutics is a biopharmaceutical company focused on developing and commercializing treatments for sickle cell disease and other serious blood disorders.
Explore Global Blood Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.